Ready to play
Ready to play
Researchers have developed an intelligent biological system capable of automatically monitoring blood sugar levels and releasing a glucose-lowering medication when needed, potentially opening new avenues for diabetes treatment. The system is based on genetically modified bacteria that carry a glucose sensor, which activates the secretion of the hormone GLP-1 that stimulates insulin release and lowers blood sugar when it rises. Experiments on mice and monkeys have shown that the system self-regulates, reduces insulin resistance, improves metabolism and cholesterol levels, and has the potential to decrease side effects associated with traditional medications. However, transforming this system into a clinical therapy requires further studies to ensure safety, stability, and proper regulation.
Notice: This Is an AI-Generated Summary
Comments (0)